QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AURA

QT59Aura Biosciences, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
6.34
+0.03+0.48%
OverviewShort InterestFilings
AURAQT59Aura Biosciences, Inc.·NASDAQ
OverviewShort InterestFilings
6.34+0.48%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own17.45%
Shs Outstand103.39M
Perf Week2.09%
Market Cap405.10MForward P/E-EPS next Y-1.67Insider Trans-6.84%Shs Float-Perf Month-14.21%
Enterprise Value337.30MPEG-EPS next Q-0.41Inst Own-Short Float-Perf Quarter-3.65%
Income-106987065.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y2.59%
Sales-P/B3.97EPS next Y-4.55%ROA-81.64%Short Interest-Perf YTD16.33%
Book/sh1.03P/C-EPS next 5Y-ROE-78.12%52W High9.54 -33.54%Perf Year2.59%
Cash/sh1.11P/FCF-EPS past 3/5Y-ROIC-95.48%52W Low4.73 34.04%Perf 3Y-
Dividend Est.-EV/EBITDA-3.03Sales past 3/5Y-Gross Margin0.00%Volatility4.08% 3.40%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM0.57%Oper. Margin0.00%ATR (14)0.38Perf 10Y-
Dividend Ex-Date-Quick Ratio7.09Sales Y/Y TTM-Profit Margin0.00%RSI (14)36.08Recom2.00
Dividend Gr. 3/5Y-Current Ratio7.09EPS Q/Q9.09%SMA20-7.34%Beta1.61Target Price17.00
Payout0.00%Debt/Eq0.16Sales Q/Q-SMA50-12.29%Rel Volume2.11Prev Close6.31
Employees106LT Debt/Eq0.10EarningsAug 12SMA2001.45%Avg Volume598.03KPrice6.34
IPO DateOct 29, 2021Option/ShortYes / YesEPS/Sales Surpr.-25.00% -Net Debt/EBITDA0.61Volume1,263,808Change0.48%
Analyst Ratings
DateActionAnalystRatingTarget
May-12-26ReiteratedLeerink Partners$26 → $17
Mar-26-25ReiteratedJMP SecuritiesMarket Outperform$30 → $19
Mar-25-25ReiteratedH.C. Wainwright$22 → $25
Oct-18-24ReiteratedH.C. Wainwright$21 → $22
Oct-18-24ReiteratedBTIGBuy$24
Oct-18-24ReiteratedScotiabankSector Outperform$23
Jul-25-24InitiatedH.CBuy$21
Nov-11-22ReiteratedJMP SecuritiesMarket Outperform$30
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A001
Gross Profit00-1
Selling, General and Administrative Excl. Other222320
Research and Development907364
Other Operating Expense100
Operating Income-113-96-85
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-7-9-9
Net Income Before Taxes-106-87-76
Income Taxes
000
Consolidated Net Income-106-87-76
Net Income From Continuing Operations-106-87-76
Net Income-106-87-76
EPS (Recurring)-1.76-1.75-1.93
EPS (Basic, Before Extraordinaries)-1.76-1.75-1.93
EPS (Diluted)-1.76-1.75-1.93
EBITDA-105-86-75
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding605040
Market Capitalization327——
Operating Lease Expense
———
Insider Trading Volume
$7.01$6.37$5.72$5.08$4.44● Close Price0.00M9.76M19.52M29.28M39.04MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Gibney Anthony SSee RemarksJun 16 '26Sale6.4212,82482,330265,354Jun 16 12:00 AM
Matrix Capital Management Company, LP10% OwnerMay 07 '26Sale5.646,922,87039,044,9870May 11 12:00 AM
Kilroy ConorSee RemarksApr 16 '26Sale7.0211,73882,401217,835Apr 16 12:00 AM
Kilroy ConorSee RemarksFeb 17 '26Sale5.0512,07960,999167,234Feb 17 12:00 AM
Plavsic MarkChief Technology OfficerFeb 17 '26Sale5.0515,89080,245181,397Feb 17 12:00 AM
Hopkins Janet JillChief Medical OfficerFeb 17 '26Sale5.0620,401103,229232,284Feb 17 12:00 AM
Elazzouzi AmySenior Vice President, FinanceFeb 17 '26Sale5.068,54943,25875,532Feb 17 12:00 AM
de los Pinos ElisabetSee RemarksFeb 17 '26Sale5.0647,648241,099409,815Feb 17 12:00 AM
Elazzouzi AmySenior Vice President, FinanceJan 20 '26Sale4.861,5817,68484,081Jan 20 12:00 AM
de los Pinos ElisabetSee RemarksJan 20 '26Sale4.8616,92882,270457,463Jan 20 12:00 AM
Hopkins Janet JillChief Medical OfficerNov 17 '25Sale5.4217,10992,731252,685Nov 17 12:00 AM
Elazzouzi AmySenior Vice President, FinanceOct 29 '25Sale6.358965,69085,662Oct 29 12:00 AM
de los Pinos ElisabetSee RemarksOct 29 '25Sale6.359,04957,461474,391Oct 29 12:00 AM
Plavsic MarkChief Technology OfficerOct 16 '25Sale6.3512,16977,273197,287Oct 16 12:00 AM
Elazzouzi AmySenior Vice President, FinanceAug 18 '25Option Exercise3.8924,70496,21394,280Aug 18 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR